Top Markets
Coin of the day
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd

017180
Pozycja w akcjach #28117
MYUNGMOON Pharm Co., Ltd. operates as a pharmaceutical enterprise,... MYUNGMOON Pharm Co., Ltd. operates as a pharmaceutical enterprise, comprehensively handling the research, development, production, distribution, and commercialization of medicinal products. Its business activities extend across South Korea and into global markets. The company offers an extensive array of prescription drugs, addressing a broad spectrum of medical conditions. This range includes treatments for musculoskeletal issues like osteoarthritis, inflammation, rheumatoid arthritis, and muscle relaxation, alongside anti-infectives (antibiotics and antifungals), respiratory aids, and gastrointestinal therapeutics. Cardiovascular health is targeted with circulation agents, anti-hypertensive drugs, and antidiabetic medications. Furthermore, their specialized pharmacotherapy solutions cover narcotics, anesthetics, central nervous system agents, female hormone products, osteoporosis treatments, urogenital medications, adrenocortical hormones, oncology drugs, dermal fillers, and anti-obesity agents. Beyond prescription items, MYUNGMOON Pharm also supplies a diverse selection of over-the-counter (OTC) remedies. These encompass medications for nausea, genitourinary concerns, gum disease, liver support, parasitic infections, constipation, oral ailments, diarrhea, and general digestive health. The OTC portfolio further includes cold and flu treatments, calcium supplements, nasal sprays, multi-vitamins, eye nutrition products, eye drops, blood circulation enhancers, and topical preparations such as external skin treatments and localized pain relievers. In addition to its pharmaceutical lines, the firm markets health supplements, quasi-pharmaceuticals, and blended juice beverages. Established in 1983, MYUNGMOON Pharm Co., Ltd. maintains its primary corporate office in Seoul, South Korea.
Cena akcji
$0.84293068
Kapitalizacja rynkowa
$28.18M
Zmiana (1 dzień)
1.92%
Zmiana (1 rok)
-29.90%
Kraj
KR
Handel MYUNGMOON Pharm co.,Ltd (017180)

Kategoria

Cena 017180 z kapitalizacją rynkową B
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
017180
$0.84293068
Kapitalizacja rynkowa MYUNGMOON Pharm co.,Ltd(017180)
Kapitalizacja rynkowa: $28.18M
Na dzień August 2026 spółka MYUNGMOON Pharm co.,Ltd ma kapitalizację rynkową wynoszącą $28.18M. Według naszych danych, czyni to MYUNGMOON Pharm co.,Ltd 28117th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej MYUNGMOON Pharm co.,Ltd od 2008 do 2026
017180 w porównaniu do 5 najpopularniejszych stocks
Cena za 017180 Aktywa B Kapitalizacja rynkowa B Wyniki
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
$158,564 $28.18M
$5.301T +18,810,889.37%
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
$138,612 $28.18M
$4.634T +16,443,932.10%
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
$123,928 $28.18M
$4.143T +14,701,938.95%
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
$107,368 $28.18M
$3.589T +12,737,371.11%
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd
$85,459.22 $28.18M
$2.857T +10,138,245.37%